Related Experiment Video
Updated: Jun 28, 2026

Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
Interpretable multi-instance heterogeneous graph network learning modelling CircRNA-drug sensitivity association
Mengting Niu1,2,3, Chunyu Wang4, Yaojia Chen1,5,6
1Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, China.
Background:
Different expression levels of circular RNAs (circRNAs) affect the sensitivity of human cells to drugs, thus producing different responses to the therapeutic effects of drugs. Using traditional biomedical experiments to discover and confirm sensitivity relationships is not only time-consuming but also costly. Therefore, developing an effective method to accurately predict new associations between circRNAs and drug sensitivity is crucial and urgent. Therefore, we constructed a heterogeneous graph network MiGNN2CDS on the basis of multi-instance learning (MIL).
Results:
We first extracted similar features of circRNAs and drugs and the structural features of drugs to construct a heterogeneous network. To learn the deep embedding features of the heterogeneous network, we designed a heterogeneous graph convolutional network (GCN) architecture. By introducing instance learning, we subsequently designed a pseudo-metapath instance generator and a bidirectional translation embedding projector BiTrans to learn the metapath-level representation of circRNA-drug pairs. Finally, an interpretable multiscale attention network joint predictor was designed to achieve accurate prediction and interpretable analysis of circRNA-drug sensitivity associations.
Conclusions:
MiGNN2CDS achieves better prediction accuracy than many state-of-the-art models do. Case studies show that MiGNN2CDS can effectively predict unknown associations, and the model interpretability of MiGNN2CDS is verified by high-confidence meta-path analysis. The code and data are available at https://github.com/nmt315320/MiGNN2CDS.git .
Insights
Predicting drug sensitivity associations with circular RNAs (circRNAs) is vital for personalized medicine. A new method, MiGNN2CDS, leverages multi-instance learning and graph networks to accurately identify these crucial circRNA-drug relationships.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Circular RNAs (circRNAs) influence drug sensitivity in human cells, impacting therapeutic outcomes.
- Traditional experimental methods for identifying circRNA-drug sensitivity associations are inefficient and costly.
- Accurate prediction of novel circRNA-drug sensitivity relationships is essential for advancing personalized medicine.
Purpose of the Study:
- To develop an effective computational method for predicting circRNA-drug sensitivity associations.
- To construct a heterogeneous graph network model integrating circRNA and drug features.
- To enhance the accuracy and interpretability of circRNA-drug sensitivity predictions.
Main Methods:
- Constructed a heterogeneous network using circRNA features, drug features, and drug structural information.
- Employed a heterogeneous graph convolutional network (GCN) for deep feature embedding.
- Integrated multi-instance learning (MIL) with a pseudo-metapath instance generator and BiTrans for metapath-level representation.
- Developed an interpretable multiscale attention network for final prediction and analysis.
Main Results:
- The MiGNN2CDS model demonstrated superior prediction accuracy compared to existing state-of-the-art methods.
- Case studies confirmed the model's capability in predicting previously unknown circRNA-drug associations.
- Model interpretability was validated through high-confidence meta-path analysis.
Conclusions:
- MiGNN2CDS offers a powerful and interpretable approach for predicting circRNA-drug sensitivity.
- The findings contribute to the development of targeted therapies by identifying key circRNA biomarkers.
- The study provides a valuable computational tool for drug sensitivity research, with code and data publicly available.
Related Concept Videos
Quantitative Aspects of Drug-Receptor Interaction
Pharmacogenomics: Identification of New Drug Targets

